(Q37899895)

25 August 2017

1 reference

title

HIV-related neurocognitive impairment--a review (English)

1 reference

25 August 2017

0 references

Simon Rackstraw

1

1 reference

25 August 2017

publication date

11 July 2011

1 reference

Psychology, Health and Medicine

25 August 2017

published in

1 reference

25 August 2017

volume

16

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

548-563

1 reference

Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Updated research nosology for HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Impact of Human Immunodeficiency Virus Type-1-Associated Cognitive Dysfunction on Activities of Daily Living and Quality of Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Early viral brain invasion in iatrogenic human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

The neuropathogenesis of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neuropsychological impairment in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

A multimodal assessment of driving performance in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

HIV dementia: an evolving disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

The frequency and profile of neurology in black South African HIV infected (clade C) patients - a hospital-based prospective audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Natural history of HIV infection in the era of combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

The AIDS dementia complex: I. Clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

A Trojan Horse mechanism for the spread of visna virus in monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

The AIDS dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neuropsychiatric impact of hepatitis C on advanced HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Improved cognitive function as a consequence of hepatitis C virus treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Anti-HIV drug distribution to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Diabetes, insulin resistance, and dementia among HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Spanish validation of the HIV dementia scale in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Neuroprotective and anti-human immunodeficiency virus activity of minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

HIV-associated prospective memory impairment in the laboratory predicts failures on a semi-naturalistic measure of health care compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Psychiatric aspects of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13548506.2011.579992

10.1080/13548506.2011.579992

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference